The U.S. government has been discussing with drugmakers how to raise overseas drug prices as President Donald Trump seeks to ...

Lilly has been chasing—and gaining on—its chief metabolic medicine rival Novo Nordisk and its counterpart GLP-1s Ozempic and ...

Following a barrage of letters from President Donald Trump urging 17 large pharmaceutical companies to implement Most Favored ...

US President Donald Trump recently announced tariffs as high as 100% on certain semiconductor products. Although South Korea ...

It’s a bad time to try to predict future pharmaceutical prices.

Presidential office said on Aug. 7 that the United States had pledged most-favored-nation (MFN) treatment on future ...

The Trump administration seeks higher overseas drug prices as it plans to impose Most Favored Nation policy, which aims to cut U.S. drug prices. Read more here.

Trump’s MFN price controls on drugs will harm U.S. companies and patients.

The Trump Administration is pursuing decidedly anti-growth policies. The results will be a weaker economy that violates his ...

Late last week, President Donald Trump sent letters to 17 pharmaceutical companies pressing them to deliver on his May ...

BACKGROUND Since taking office on January 20, 2025, the Trump Administration has undertaken an aggressive trade policy that ...